UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$577.34−6.76 (-1.16%)
Close on Nov 18, 2026Market cap $24.76BP/E 20.7Yield –
United Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
United Therapeutics's market cap was $25.42B on Nov 11, 2026, against $20.85B a year earlier. Over the last 5 years it ranged from $7.50B to $25.88B, with a median of $12.75B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $25.42B | +21.6% |
| 2025 | Dec 31, 2025 | $20.90B | +32.8% |
| 2024 | Dec 31, 2024 | $15.74B | +52.4% |
| 2023 | Dec 29, 2023 | $10.33B | -18.5% |
| 2022 | Dec 30, 2022 | $12.67B | +30.2% |
| 2021 | Dec 31, 2021 | $9.73B | +44.2% |
| 2020 | Dec 31, 2020 | $6.75B | +74.5% |
| 2019 | Dec 31, 2019 | $3.87B | -18.6% |
| 2018 | Dec 31, 2018 | $4.75B | -25.7% |
| 2017 | Dec 29, 2017 | $6.39B | +4.5% |
| 2016 | Dec 30, 2016 | $6.12B | -14.3% |
| 2015 | Dec 31, 2015 | $7.14B | +16.2% |
| 2014 | Dec 31, 2014 | $6.14B | +8.3% |
| 2013 | Dec 31, 2013 | $5.67B | +107.6% |
| 2012 | Dec 31, 2012 | $2.73B | -0.8% |
| 2011 | Dec 30, 2011 | $2.76B | -23.2% |
| 2010 | Dec 31, 2010 | $3.59B | +48.9% |
| 2009 | Dec 31, 2009 | $2.41B | – |
See a number that looks wrong?